Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients

Aupérin, 2010, Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer, J Clin Oncol, 28, 2181, 10.1200/JCO.2009.26.2543 Non-Small Cell Lung Cancer collaborative Group, 2010, Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer, Cochrane Database Syst Rev, 5, CD007309 Schiller, 2002, Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer, N Engl J Med, 346, 92, 10.1056/NEJMoa011954 Ashworth, 2013, Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature, Lung Cancer, 82, 197, 10.1016/j.lungcan.2013.07.026 Salah, 2012, Metastatectomy for extra-cranial extra-adrenal non-small cell lung cancer solitary metastases: systematic review and analysis of reported cases, Lung Cancer, 75, 9, 10.1016/j.lungcan.2011.07.014 Yano, 2010, Prognostic impact of local treatment against postoperative oligometastases in NSCLC, J Surg Oncol, 102, 852, 10.1002/jso.21750 Alongi, 2012, Review and uses of stereotactic body radiation therapy for oligometastases, Oncologist, 17, 1100, 10.1634/theoncologist.2012-0092 Tree, 2013, Stereotactic body radiotherapy for oligometastases, Lancet Oncol, 14, 28, 10.1016/S1470-2045(12)70510-7 De Ruysscher, 2012, Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial, J Thorac Oncol, 7, 1547, 10.1097/JTO.0b013e318262caf6 Griffioen, 2013, Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors, Lung Cancer, 82, 95, 10.1016/j.lungcan.2013.07.023 Rusch, 2009, The IASLC Lung Cancer Staging Project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer, J Thorac Oncol, 4, 568, 10.1097/JTO.0b013e3181a0d82e Engels, 2011, Phase II study of helical tomotherapy for oligometastatic colorectal cancer, Ann Oncol, 22, 362, 10.1093/annonc/mdq385 Engels, 2012, Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer, Radiat Oncol, 7, 34, 10.1186/1748-717X-7-34 Wahl, 2009, From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors, J Nucl Med, 50, 122S, 10.2967/jnumed.108.057307 Milano, 2012, Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study, Int J Radiat Oncol Biol Phys, 83, 878, 10.1016/j.ijrobp.2011.08.036 Hasselle, 2012, Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer, J Thorac Oncol, 7, 379, 10.1097/JTO.0b013e31824166a5 De Vin, 2014, Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival, Ann Oncol, 25, 467, 10.1093/annonc/mdt537 Paz-Ares, 2013, PARAMOUNT: final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer, J Clin Oncol, 31, 2895, 10.1200/JCO.2012.47.1102 Palma, 2012, Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial, BMC Cancer, 12, 305, 10.1186/1471-2407-12-305